How many institutions held TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value in Q3 2022?

90 institutional investors reported TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value for Q3 2022. Use the holders table for investor-level position and value details.

TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)

Q: What does CUSIP 89455T109 represent in this 13F holders report?

CUSIP 89455T109 is the security identifier for TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 89455T109

Q3 2022 13F Holders as of 30 Sep 2022

Security type / class: Equity / Common stock, $0.001 par value
Total 13F shares: 26,104,333
Total 13F value: $576,118,458
Share change: +2,983,935
SEC-reported price per share: $22.07
Number of holders: 90
Value change: +$73,324,010
Number of buys: 57
Number of sells: 33
Shares outstanding: 65,005,107

Security key

89455T109

Report period

Q3 2022

Institutions

Top holders

TMCI full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 TREACE MEDICAL CONCEPTS, INC. SEC filings TREACE MEDICAL CONCEPTS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 89455T109

Newer quarter: Q3 2025

Recent filing periods:

Q3 2026 Q3 2025

Ownership snapshot

Top reported holders of TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

John R. Treace

Disclosed value leader

John R. Treace

Comparable rows

0/15

Latest evidence

30 Jun 2022

3/4/5 13F Highest disclosed value: $59,159,875 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

John R. Treace has the largest disclosed position value at $59.16M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens John R. Treace's linked filing trail.

Disclosed position value Top 5

John R. Treace $59.16M

ALLIANCEBERNSTEIN L.P. $47.39M

VANGUARD GROUP INC $42.07M

BlackRock Finance, Inc. $26.44M

NEXT CENTURY GROWTH INVESTORS LLC $24.97M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
John R. Treace	3/4/5 Director 3/4/5	— denominator unverified	$59,159,875 2,231,606 shares	—	09 May 2022
ALLIANCEBERNSTEIN L.P.	13F Company 13F	— denominator unverified	$47,393,000 3,304,942 shares	—	30 Jun 2022
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$42,074,000 2,934,041 shares	—	30 Jun 2022
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$26,438,000 1,843,561 shares	—	30 Jun 2022
NEXT CENTURY GROWTH INVESTORS LLC	13F Company 13F	— denominator unverified	$24,968,000 1,741,154 shares	—	30 Jun 2022
CIBC Private Wealth Group LLC	13F Company 13F	— denominator unverified	$16,343,000 1,139,709 shares	—	30 Jun 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

26,104,333

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q3 2025 Across Filers

Q3 2025 holders

117

Q3 2022 holders

Holder diff

-27

Investor	Q3 2025 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q3 2025 value	Q3 2022 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend